No profile data available.
Bal Pharma Limited (BALPHARMA.NS) is a healthcare company in the drug manufacturing contractors industry, based in Bengaluru, India, with about 939 full-time employees.
It reported revenue of 2.94 billion INR for fiscal year 2025, down 9.8% from fiscal year 2024, and net income of 72.15 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 876.90 million INR, up 19.9% from a year before. Exports was its largest region in fiscal year 2025, with 62% of revenue. Its market capitalization was 1.47 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs.
Bal Pharma reported 2.94 billion INR in revenue for fiscal year 2025, down 9.8% from 3.26 billion INR in fiscal year 2024. In Q3 2026 revenue was 876.90 million INR.
Exports: 62% of revenue by region in fiscal year 2025, followed by India (38%).
1.47 billion INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Natural Capsules Limited (NATCAPSUQ.BO), Kimia Biosciences Limited (KIMIABL.BO), Godavari Drugs Limited (GODAVARI.BO), Par Drugs and Chemicals Limited (PAR.NS).